Viralgen and Axovia Therapeutics are set to form a partnership to progress the development and manufacturing of an ...

The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the ...

New Vericheck ddPCR Empty-Full Capsid Kits for AAV Serotypes 2 and 8 Provide Precise Measurement of Viral Titer and Capsid ...

Viralgen and Axovia Therapeutics are partnering to develop and manufacture a gene therapy for the treatment of retinal ...

Adeno-Associated Virus (AAV): A small virus that is commonly used as a vector to deliver genetic material into cells for gene therapy. Gene Therapy: A technique that modifies a person's genes to ...

Press release Genethon and Eukarÿs announce a strategic partnership to develop a breakthrough technology to reduce the ...

Viralgen and Axovia Therapeutics are joining forces to advance the development and manufacture of an AAV9-based inv ...

Dyno was founded in 2018 and applies artificial intelligence (AI) and quantitative in vivo experiments to address gene therapy’s delivery challenge. Naturally occurring AAV capsids lack precise ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...